Fund Focus: Life Sciences & Global Health

The life sciences sector of the economy offers to bring better healthcare, quality of life and a better understanding of diseases that affect us all.

Some very high tech companies are working in this area, take mySymptoms from Skygazerlabs, [www.skygazerlabs.com] a privately held business, that has some very clever technology.

One can get access to quoted (listed) Bio Tech and Pharma companies with investment funds like the Legal & General Global Health and Pharmaceuticals Index Trust

[http://i.legalandgeneral.com/consumer/investments/products-and-funds/index-tracker/investments-productsandfunds-indextracker-fund-globalhealthandpharm.jsp]

The top 10 holdings in the fund portfolio are:

Johnson & Johnson (US)
Pfizer (US)
Novartis (Switzerland)
Roche (Switzerland)
Merck & Company (US)
Sanofi (France)
GlaxoSmithKline (UK)
Novo Nordisk (Denmark)
Amgen (US)
AstraZeneca (UK)

These represent almost 50% of the Trust by market value and consist of the 10 largest pharmaceutical companies in the world.

A £63,952,194 fund (£63.9 million) that gives access to the one of the most critical sectors of the market.

Leave a Reply

Your email address will not be published. Required fields are marked *